Strides gains USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg EP News Bureau Sep 6, 2024 Strides is eligible for 180 days of Competitive Generic Therapy (CGT) exclusivity for Theophylline Extended-Release Tablets, 300…
Lupin launches generic version of Brovana in US EP News Bureau Jun 3, 2021 It is indicated for the long-term, twice-daily maintenance treatment of bronchoconstriction in patients with COPD
